On Nov. 16, 2021, Illumina and Genetic Alliance announced the creation of the iHopeﾙ Genetic Health program aimed at providing whole-genome sequencing access (WGS) to tens of thousands of patients across the globe impacted by genetic disease.

At least half of iHope Genetic Health’s efforts were focused on areas of the world in need outside the US, with more than one-third of Illumina’s support being dedicated to patients in Africa.